WASHINGTON, April 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended March 31, 2023 net earnings were $1.4 billion, or $1.94 per diluted common share and non-GAAP adjusted diluted net earnings per... Read more
Advancements in NMR enable deeper insights into life science, drug discovery, and cleantech ASILOMAR, Calif.–(BUSINESS WIRE)– At the Experimental Nuclear Magnetic Resonance Conference (ENC 2023), Bruker announces innovations for NMR spectroscopy in life science, pharma, and cleantech research to enable discoveries in functional structural biology, drug discovery, and battery research. Ascend Evo 400 NMR magnet... Read more
Universities of Warwick and Birmingham to receive 1.2 GHz NMRs for Enabling Life-Science and Green-Tech Research throughout the United Kingdom COVENTRY, United Kingdom–(BUSINESS WIRE)– Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance™ nuclear magnetic resonance (NMR) spectrometers for the University of Warwick and... Read more
Q4 2022 revenues $708.4 million, up 3.6% year-over-year (yoy); organic revenue growth of 8.9% Q4 2022 GAAP EPS $0.66; non-GAAP EPS $0.74, up 25.4% yoy FY 2022 revenues $2.531 billion, up 4.7% yoy; organic revenue growth of 10.2% FY 2022 GAAP EPS $1.99; non-GAAP EPS $2.34, up 11.4% yoy Bruker expects FY 2023 organic revenue... Read more
Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto WASHINGTON, Feb. 8, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) today announced that Veralto Corporation (“Veralto” or the “Company”) will be the name of the separate public company Danaher intends to create in the fourth quarter of 2023. Veralto will be comprised... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter and Full Year 2022 Highlights Fourth quarter revenue grew 7% to $11.45 billion. Fourth quarter GAAP diluted earnings per share (EPS) was... Read more
WASHINGTON, Jan. 24, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2022. All results in this release reflect only continuing operations unless otherwise noted. Net earnings refers to net earnings attributable to common shareholders. For the quarter ended December 31, 2022, net earnings were... Read more
Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma Complements Existing Specialty Diagnostics Offering with Established Technologies Delivering Strong Clinical Value for Patients in a Rapidly Growing Diagnostics Segment WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today... Read more
Company to achieve 2030 Scope 1 and 2 greenhouse gas emissions reduction target of 30% ahead of schedule; increases ambition to 50% reduction, aligned with 1.5˚C pathway WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a new 2030 greenhouse gas emissions reduction target to reduce its... Read more
This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more